ReviewHerz2021
Valvular heart disease in patients with chronic kidney disease.
Review in Herz, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06660524 (Clinical Study on the Influence of Calcium and Phosphorus Regulation Therapy on Valvular Heart Disease.), which is not on this map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Study on the Influence of Calcium and Phosphorus Regulation Therapy on Valvular Heart Disease.
Who cites it
19 citing papers in PubMed, 23 citations in OpenAlex.
- Multivalvular Involvement in Acute Heart Failure: Associations with One-Year Outcomes and the Right-Heart Phenotype.Medical sciences (Basel, Switzerland) · 2026Article
- The Prognostic Significance of Functional Mitral Regurgitation in Patients with Cardiovascular-Kidney-Metabolic Syndrome.Journal of clinical medicine · 2026Article
- Add-Ons of Heart Disease from the Cardiosurgical Perspective: Gender, Blood Groups and Renal Function.Medical sciences (Basel, Switzerland) · 2026Article
- Chronic kidney disease and valvular heart disease: State of the art.Physiological reports · 2025Review
- Exploring the Interplay Between Kidney Dysfunction and Cardiovascular Disease.Medical sciences (Basel, Switzerland) · 2025Review
- Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies.Clinical kidney journal · 2025Article
- Independent risk factors and outcomes for ventilator-associated pneumonia due to multidrug-resistant organisms after cardiac valvular surgery.Frontiers in cardiovascular medicine · 2025Article
- Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease.International journal of molecular sciences · 2024Review
- The number of valvular insufficiency is a strong predictor of cardiovascular and all-cause mortality in hemodialysis patients.International urology and nephrology · 2023Article
- Left-sided valvular heart disease in dialysis recipients: a single-centre observational study.Clinical kidney journal · 2023Article
- Native Mitral Valve Endocarditis Caused by a Non-HACEK Gram-Negative Pathogen in a Hemodialysis Patient.Journal of medical cases · 2023Article
- The influence of renal disease on outcomes and cardiac remodeling following surgical mitral valve replacement.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Article
- The 40th Anniversary of Percutaneous Balloon Valvuloplasty for Mitral Stenosis: Current Status.Structural heart : the journal of the Heart Team · 2022Review
- Regression Models to Study the Total LOS Related to Valvuloplasty.International journal of environmental research and public health · 2022Article
- Valvular Heart Disease in Patients with Chronic Kidney Disease.European cardiology · 2022Review
- Increased TGFβ1 and SMAD3 Contribute to Age-Related Aortic Valve Calcification.Frontiers in cardiovascular medicine · 2022Article
- Preoperative Cardiovascular Assessment of the Renal Transplant Recipient: A Narrative Review.Journal of clinical medicine · 2021Review
- Cardiac Involvement in Chronic Kidney Disease: Epidemiology, Pathophysiology, and Complications.Heart views : the official journal of the Gulf Heart AssociationReview
- Renal Function Improvement after Aortic Valve Replacement in a Patient with Chronic Kidney Disease - A Case Report.Heart views : the official journal of the Gulf Heart AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Valvular heart disease (VHD) is common in patients with impaired renal function, especially in those with end-stage renal disease (ESRD) undergoing dialysis. Progressive sclerosis and calcification of the valves and valvular annuli are major components of the etiology. These processes typically affect the aortic and mitral valve and can lead to both valvular insufficiency and stenosis. As recommended by the 2017 ESC/EACTS Guidelines for the management of VHD, surgical treatment remains the standard care for most cases of severe VHD. However, chronic kidney disease (CKD) is associated with increased mortality when compared with patients with preserved renal function. Interventional treatment options have emerged as an effective and safe alternative for patients older than 75 years and/or with increased surgical risk. Consequently, in patients with CKD at increased surgical risk who have suitable anatomical morphology, transcatheter replacement and/or repair should be discussed in the interdisciplinary "heart team."
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.